Connect with us

Health

More than half of Americans with STDs were infected by cheating partners, survey finds

Published

on

More than half of Americans with STDs were infected by cheating partners, survey finds

A new study has exposed the sexual health habits of some Americans.

Researchers analyzed data from the U.S. Census Bureau to determine how and where Americans have been contracting and spreading STIs (sexually transmitted infections), also known as STDs (sexually transmitted diseases).

Among the findings from DatingNews.com was the fact that 55% of people with an STI contracted it from a cheating partner.

TESTOSTERONE THERAPY COULD HELP BOOST WOMEN’S SEX DRIVE AS THEY AGE, BUT RISKS EXIST, EXPERTS SAY

Thirteen percent of the nearly 1,000 respondents said their partner has lied to them about their STI status, while 45% did not discuss testing with their partner before becoming sexually active.

Advertisement

Nearly one in five (18%) of respondents said they had been diagnosed with an STI, with the most common diagnosis, chlamydia, making up 36% of the cases.

Fifty-five percent of people with an STI said they contracted it from a cheating partner, according to the study. (iStock)

The survey participants ranged in age from 18 to 79, DatingNews.com spokesperson Emily Fanous told Fox News Digital.

Since 81% of Americans over 18 are sexually active, Fanous emphasized the importance of knowing one’s risk — and how getting testing can aid in prevention.

FIRST AT-HOME SYPHILIS ANTIBODY TEST GETS FDA AUTHORIZATION AS STD CASES SPIKE IN US

Advertisement

One in three Americans in the study said they have never been tested for an STI.

The largest number of untested individuals were baby boomers (51%), followed by millennials (33%) and Gen Z and Gen X (both 29%).

The main reasons respondents said they’ve refrained from testing are embarrassment (25%), lack of time (22%) and cost (19%).

Baby boomers made up 51% of individuals who had never been tested for STDs. (iStock)

Dr. Gabe Gaviola, M.D., senior medical director at Everlywell in New York — an at-home STD testing and treatment platform — noted that there are more than 20 million new cases of STIs reported in the U.S. each year.

Advertisement

“The real surprise from these findings is the lack of STI testing that could prevent new cases,” Gaviola, who was not involved in the study, told Fox News Digital during an on-camera interview. (See the video at the top of this article.)

“Many STIs don’t present any symptoms, which means you shouldn’t wait for symptoms to get tested.”

“As a doctor and public health advocate, I wish more people knew that there are affordable at-home STI lab testing options that provide quick, reliable results with the privacy and convenience of collection at home.”

“I wish more people knew that there are affordable at-home STI lab testing options that provide quick, reliable results with the privacy and convenience of collection at home,” said a sexual health expert. (iStock)

The study also found that only 34% of people get annual STI testing, while fewer than 25% get tested before entering a new relationship.

Advertisement

“Those numbers aren’t high enough,” Gaviola said. “Many STIs don’t present any symptoms, which means you shouldn’t wait for symptoms to get tested.” 

STDs by state

The research also revealed the U.S. states that have the most STI and STD cases.

Mississippi has the highest rate, at 1,187 diagnoses per 100,000 people, followed by Louisiana at 1,145, Alaska at 1,066, South Dakota at 993 and Georgia at 975.

Fanous encouraged those in states with high rates to consider being tested if they are sexually active.

For more Health articles, visit www.foxnews.com/health

Advertisement

“These findings show that too many people are not prioritizing their sexual health,” Gaviola said. 

“Whether it’s because of stigma, access or education, millions of Americans who are at high risk of getting or transmitting an STI are not getting tested.”

“We need to advance the conversation around sexual health and increase education about the importance of STI testing.”

“Whether it’s because of stigma, access or education, millions of Americans who are at high risk of getting or transmitting an STI are not getting tested,” an expert said. (iStock)

Everlywell is teaming up with the American Sexual Health Association for the first-ever National Get Tested Day on Sept. 30.

Advertisement

“Testing is the first step in empowering people with important information about their sexual health.”

“Our goal is to educate and break down barriers to accessing this essential health care,” Gaviola said. 

“Testing is the first step in empowering people with important information about their sexual health.”

Sexual health experts encourage routine STI testing, even for people in long-term, monogamous relationships. (iStock)

Gaviola added that even people in long-term, monogamous relationships should stay up to date on STI testing.

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“Many STIs don’t present any symptoms, but if left undetected and untreated, they can lead to serious long-term health issues, such as infertility,” he cautioned.

The expert encouraged Americans to have open conversations with their partners before entering a sexual relationship and to “keep checking in.”

“This helps establish trust that they are taking their sexual health as seriously as you are by getting tested regularly,” he said.

Advertisement

Health

New cancer vaccine delivers stunning result against one of the deadliest skin cancers

Published

on

New cancer vaccine delivers stunning result against one of the deadliest skin cancers

NEWYou can now listen to Fox News articles!

A new injectable therapy is showing positive results in reducing melanoma throughout a five-year period.

The personalized mRNA cancer therapy, called intismeran autogene, combined with the cancer immunotherapy drug KEYTRUDA (pembrolizumab), is a collaboration between Merck and Moderna.

The results from the phase 2b KEYNOTE-942 study were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago on May 27.

CLICK HERE FOR MORE HEALTH STORIES

Advertisement

After about a five-year follow-up, the combo drug was found to reduce the risk of melanoma recurrence or death by 49% compared to pembrolizumab alone.

The researchers analyzed data from 157 patients with high-risk stage 3 and 4 melanoma whose cancer had been removed via surgery. The participants were split into two groups — one received the combo therapy and the other only received pembrolizumab, according to a press release.

The therapy was found to reduce the risk of melanoma recurrence or death by 49% compared to pembrolizumab alone after a five-year follow-up. (iStock)

The findings revealed that the combination group saw benefits that were “sustained and durable over time.”

Intismeran autogene is designed using mutations identified in a patient’s own tumor, with the intention of teaching the immune system what the cancer looks like so that it can recognize and attack it.

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

According to the researchers, intismeran is “well-tolerated” with a “manageable” safety profile. 

The most commonly cited side effects of the personalized mRNA vaccine plus KEYTRUDA were fatigue, injection-site pain, chills, fever and headache. The researchers reported no new long-term safety concerns and no severe vaccine-related adverse events.

The combination therapy is currently being evaluated in a phase 3 study — the final confirmation stage.

Patients with late-stage melanoma have a “significant risk” of cancer recurrence, according to an expert. (iStock)

Advertisement

In a Merck press release from January, Kyle Holen, MD, Moderna’s senior vice president and head of development, oncology and therapeutics, noted that this data highlights the “potential of a prolonged benefit … in patients with resected high-risk melanoma.”

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“We continue to invest in our platform in oncology because of encouraging outcomes like these, which illustrate mRNA’s potential in cancer care,” he said.  

Dr. Marjorie Green, senior vice president and head of oncology, global clinical development at Merck Research Laboratories, also commented that for many patients with stage 3 or 4 melanoma, there is a “significant risk of recurrence following surgery.”

Researchers confirmed that the combination therapy is currently being evaluated in a phase 3 study. (iStock)

Advertisement

“As such, demonstrating the longer-term potential of intismeran autogene and KEYTRUDA to reduce the risk of recurrence for certain patients with melanoma is a meaningful milestone,” she said.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

The company cited encouraging five-year follow-up data and pointed to upcoming late-stage INTerpath trial results with Moderna in several hard-to-treat cancers.

Continue Reading

Health

New ways to prevent flu revealed in ‘accidental’ lab breakthrough, study finds

Published

on

New ways to prevent flu revealed in ‘accidental’ lab breakthrough, study finds

NEWYou can now listen to Fox News articles!

An accidental lab discovery has opened the door to entirely new ways of preventing the flu.

While investigating how influenza replicates, researchers discovered that different flu strains use completely different strategies to infiltrate human cells, SWNS reported.

By targeting the specific molecules the viruses rely on, scientists found that they could block them from entering new cells and halt their replication altogether.

5 THINGS YOU NEED TO KNOW BEFORE GETTING YOUR FLU SHOT, ACCORDING TO DOCTORS

Advertisement

Researchers say these “fundamental insights” into seasonal influenza highlight a clear path toward developing better preventive medications.

“The hope is that fundamental, curiosity-based research like this helps to pave the way for novel strategies to treat and prevent influenza infections,” principal investigator Dr. Emily Bruce, from the University of Vermont’s Larner College of Medicine, said in the SWNS report.

While investigating how influenza replicates, researchers discovered that different flu strains use completely different strategies to infiltrate human cells. (iStock)

While several flu strains cause illness, H1N1 and H3N2 influenza A viruses are the most common. However, current flu tests cannot differentiate between them, and clinical treatments are identical for both.

Although vaccines and antivirals are available, Bruce noted a “dire” need for better medications to stop the virus from spreading cell to xxcell.

Advertisement

“You don’t get sick when a virus is in one cell,” he noted. “You get sick because a virus replicates itself and goes into many more cells.”

HOW LONG YOU’RE CONTAGIOUS WITH THE FLU — AND WHEN IT’S SAFE TO GO OUT

The study, which was published in The Journal of Virology, originally aimed to map how viral RNA segments are transported within cells to create new viral particles.

The team used H1N1 and H3N2 viruses isolated from the nasal passages of positive patients in 2022.

Clinical treatments remain identical for both primary strains of the flu virus. (iStock)

Advertisement

During the investigation, the team unexpectedly stumbled upon a cellular pathway that blocked the virus from entering lung cells, SWNS reported.

RESEARCHERS LOCKED FLU PATIENTS IN A HOTEL WITH HEALTHY ADULTS — NO ONE GOT SICK

The data revealed that when a specific human protein called Rab11B was depleted, H3N2 viruses failed to enter human lung cells. H1N1 viruses were completely unaffected.

Using reverse genetics, the team mapped this defect and uncovered a brand-new, H3N2-specific role for Rab11B during viral entry.

CLICK HERE FOR MORE HEALTH STORIES

Advertisement

This discovery challenged the scientific assumption that all flu viruses enter cells the same way.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“Viruses are like pirates from different countries hijacking someone’s ship,” Bruce said. “Different viruses, like different types of pirates, use different methods to get onboard.”

This discovery challenged the scientific assumption that all flu viruses enter cells the same way. (iStock)

“We had previously thought that all flu viruses used the same way to get into a cell, but we discovered that this is not true,” she went on. “H1N1 and H3N2 need different proteins to get in, and if you get rid of the right protein, a specific virus can’t get in.”

Advertisement

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

While these findings identify a critical cellular pathway for viral entry, the study was conducted using isolated cells, the researchers acknowledged.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Further research is needed to determine whether blocking the protein is safe and effective within a live, complex human respiratory system.

Bruce and the team hope to conduct further research to determine whether this Rab11B-dependency is a fundamental property of H3N2, or if it’s a trait unique to currently circulating flu strains.

Advertisement

Continue Reading

Health

One extra serving of processed meat a day linked to higher cancer risk

Published

on

One extra serving of processed meat a day linked to higher cancer risk

NEWYou can now listen to Fox News articles!

Eating processed meat like ham, sausage and bacon may be linked to a higher risk of certain types of cancer, according to new research.

While health organizations have already confirmed that processed meat can contribute to colon cancer, this study looked closer at cancers in the upper digestive tract, where the link has historically been less clear.

To understand these connections, researchers from the European Prospective Investigation into Cancer and Nutrition (EPIC), one of the world’s largest long-term nutrition and cancer cohorts, tracked the health and diets of 450,112 people across Europe for an average of 14 years. 

FREQUENT HEARTBURN MAY BE A WARNING SIGN OF A MORE DANGEROUS CONDITION, DOCTOR SAYS

Advertisement

The study group included 131,426 men and 318,686 women, according to the study’s press release.

During the follow-up period, 876 people developed stomach cancer and 215 people developed esophageal adenocarcinoma, which is cancer of the tube connecting the mouth to the stomach.

For female participants, eating both processed meat and white meat was linked to an increased risk of developing the disease. (iStock)

Researchers tracked where the stomach cancers grew, separating them into the upper part of the stomach near the throat and the lower part of the stomach.

The researchers also sorted the tumors into two categories based on how the cancer cells appeared under a microscope: intestinal, which forms more organized structures, and diffuse, in which the cells are more scattered throughout the tissue.

Advertisement

BACTERIA IN YOUR MOUTH MAY TRAVEL TO THE GUT AND TRIGGER STOMACH CANCER, RESEARCH FINDS

After adjusting for other lifestyle factors, the researchers found that for every extra 30 grams of processed meat a person ate per day, their overall risk of stomach cancer went up by 9%. Eating that same extra 30 grams a day was also linked to a 13% higher risk of esophageal adenocarcinoma.

A standard single slice of regular deli-sliced ham or lunch meat averages around 28 grams, according to USDA data and nutritional tracking databases.

An extra 20 grams of white meat, such as chicken and turkey, was linked to a 12% higher risk of cancer in the main body of the stomach. (iStock)

An extra 20 grams of white meat, such as chicken or turkey, was linked to a 12% higher risk of cancer in the main body of the stomach, the researchers noted.

Advertisement

The study also revealed differences between men and women. For male participants, only processed meat showed a clear, statistically significant link to a higher risk of stomach cancer. For female participants, however, eating both processed meat and white meat was linked to an increased risk.

CLICK HERE FOR MORE HEALTH STORIES

These findings align with global health benchmarks, particularly those established by the World Health Organization’s International Agency for Research on Cancer.

The agency has long classified processed meat as a known human carcinogen, primarily due to its strong, well-documented links to colorectal cancer.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Advertisement

However, health organizations have also consistently pointed to a potential, yet less definitive, relationship between these meats and cancers of the stomach.

Eating 30 grams of processed meat a day, or the equivalent to one slice of ham, was linked to a 13% higher risk of esophageal adenocarcinoma. (iStock)

Further scientific investigation is needed to confirm the findings and to account for other underlying risk factors, such as certain stomach infections, which could interact with dietary habits.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

A key limitation of the study is its reliance on self-reported diets, which can sometimes lead to inaccuracies in how participants recall their meat consumption over time, the researchers noted.

Advertisement

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

The findings were published in the International Journal of Cancer.

Fox News Digital reached out to the researchers requesting comment.

Continue Reading
Advertisement

Trending